General
Pharmaceutical company Pfizer asks US regulators to allow emergency use of its experimental COVID-19 vaccine
Pharmaceutical company Pfizer has formally asked US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month.
Key points:
- How much vaccine is available and when is a moving target, but initial supplies will be scarce
- Globally, Pfizer has estimated it could have 50 million doses available by year’s end
- The US Government has a contract to buy millions of Pfizer-BioNTech doses
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appeared 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
The companies said protection plus a good safety record meant the vaccine…
-
Noosa News20 hours agoMissing wills – October 2025 – Proctor
-
Noosa News12 hours agoPower outages, traffic delays after truck smashed power pole; 100 years since Greater Brisbane was formed; Lions victory set to be plastered onto a Metro
-
Noosa News20 hours agoBrisbane home prices up $93.7k in one year, outpace national trend
-
Business16 hours agoIs Nvidia stock a buy heading into October?